Navigation Links
Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System
Date:8/22/2011

NEW YORK, Aug. 22, 2011 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH) reported encouraging top-line results from the hepatobiliary cohort of the Phase II clinical trial of the Delcath chemosaturation system with melphalan in the treatment of patients with unresectable liver cancer. This study, conducted at the National Cancer Institute (USA), included four patient cohorts: hepatobiliary cancers, and metastatic cancers of neuroendocrine, ocular or cutaneous melanoma, and colorectal (adenocarcinoma) origins.  

There were nine patients with tumors of hepatobiliary origin: five hepatocellular carcinomas (HCC) and four cholangiocarcinomas.  HCC is the most common primary cancer of the liver, with approximately 500,000 new cases diagnosed worldwide annually. Both groups had positive efficacy signals. The responses were especially encouraging in the HCC cohort and consisted of confirmed partial response or durable stable disease.  The safety profile of the chemosaturation system was consistent with that previously reported for the Company's Phase 3 melanoma trial.

"The disease control and anti-tumor activity seen in the HCC arm of this Phase II study is very encouraging for primary liver cancer patients who currently face limited treatment options," said Eamonn P. Hobbs, President and CEO of Delcath System, Inc.  "We believe these results show a strong signal of efficacy, and support our plan to initiate Phase III and Phase IV trials for HCC in the second half of 2012."

Mr. Hobbs added, "We expect to announce additional data from this Phase II trial in the near future, and look forward to presenting detailed results from the metastatic neuroendocrine arm of this trial at the Cardiovascular and Interventional Radiological Society of Europe and European Society for Medical Oncology scientific meetings in September."

The trial's primary o
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011
2. Delcath Systems to Report Second Quarter Progress Update and Conduct Conference Call
3. Delcath Systems, Inc. Announces the Completion of Common Stock Offering
4. Delcath Systems, Inc. Announces the Sale of 5,000,000 Shares of Common Stock
5. Delcath on Preliminary List of Additions to Russell Microcap® Index
6. Delcath to Present at the JMP Securities Research Conference
7. Delcath Names Harold C. Mapes as Executive Vice President of Global Operations
8. Delcath Receives Notice of European Regulatory Approval for Hepatic CHEMOSAT™ Delivery System
9. Delcath to Update Investors on FDA Meeting
10. Delcath Expands Board of Directors With Appointment of Gabriel Leung
11. Delcath to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... DALLAS , September 23, 2014 ... "Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible ... Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to ... Market over the forecast period of 2014 to ... Billion by 2019, at CAGR of 9.6% from ...
(Date:9/23/2014)... , Sept. 23, 2014 CASI Pharmaceuticals, Inc. ... to the acquisition, development and commercialization of innovative therapeutics ... global market with a primary focus on ... C. Shrotriya , MD, Chairman and Chief Executive Officer ... The appointment was made in connection with the recently ...
(Date:9/23/2014)... Sept. 23, 2014 Today, DripDrop, the first ... formation of the DripDrop Foundation, with its primary ... worldwide. Utilizing scientific advancements in Oral Rehydration Therapy ... reduce dehydration and healthcare costs through strategic partnerships, ... "DripDrop has been used in disaster ...
Breaking Medicine Technology:Ablation Technologies Market Worth $3.81 Billion by 2019 2Ablation Technologies Market Worth $3.81 Billion by 2019 3Ablation Technologies Market Worth $3.81 Billion by 2019 4CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 2CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 3CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 4DripDrop Forms Foundation To Scale Relief Efforts 2
... Dec. 3, 2010 Sermo ( http://www.sermo.com ), the ... free Sermo Report titled, " Potential Replacements for Coumadin ... awareness and understanding of these products and potential barriers ... were aware that a new product, Pradaxa (dabigatran etexilate ...
... 3, 2010 VIVUS, Inc. (Nasdaq: ... present an overview of the company at two ... presentation schedule is as follows:Canaccord Genuity Cardiovascular, Diabetes ... PTNikko Hotel, San Francisco, CAPresenter: Charles Bowden, MD, ...
Cached Medicine Technology:Sermo Study shows 70% of Specialists are Ready to Replace Warfarin 2
(Date:9/23/2014)... The U.S. Pharmacopeial Convention (USP) has submitted ... (WHO) regarding the assignment of Biological Qualifiers (BQ) to ... Expert Group of the Programme of International Nonproprietary Names ... naming of all biologicals that is consistent with existing, ... these drugs. , Hence, USP supports the concept ...
(Date:9/23/2014)... Dotinga HealthDay Reporter MONDAY, Sept. ... four out of five heart attacks in men, a new study ... to have heart attacks over an average of 11 years if ... diet, exercise and weight fronts, the study found. Only ... this ultra-healthy-living category. But they were 86 percent less likely to ...
(Date:9/23/2014)... California (PRWEB) September 23, 2014 With ... items, World Gardens Café has added Vegan as an ... come fully prepared and frozen – perfect for busy ... as a fast food meal, these healthy alternatives are ... menu includes meals such as Adobe Tempeh, Caribbean Vegetable ...
(Date:9/23/2014)... CA (PRWEB) September 23, 2014 Fountain Valley ... has won their latest body transformation contest and been named ... “Jennifer was raised here in Fountain Valley and still resides ... since June 2014 and she recently signed up for one ... been phenomenal,” says owner Zenia Joyner. “In just six weeks, ...
(Date:9/23/2014)... Recently, Best Cheap Hosting USA, a popular review ... best VPS hosting suppliers in the current market. Among ... hosting is a very popular. The account owner is ... others’ websites under his name, brand or company. , ... primary hosting plans (reseller hosting and low cost shared ...
Breaking Medicine News(10 mins):Health News:USP Comments to WHO Regarding Biologics Qualifier Proposal 2Health News:Study: Healthy Lifestyle Behaviors May Prevent 80 Percent of Heart Attacks 2Health News:Study: Healthy Lifestyle Behaviors May Prevent 80 Percent of Heart Attacks 3Health News:World Gardens Café Announces Launch of New Vegan Menu 2Health News:Fountain Valley Fit Body Boot Camp Announces Winner of Fitness Boot Camp Ambassador Contest 2Health News:Best Cheap Hosting USA: Bluehost And JustHost Are Ranked As The Best VPS Hosting Suppliers 2
... of the wellbeing and inclusion of former politically motivated ... University today (Monday 14 March). Ageing and ... Ireland and the border region of Ireland investigated the ... and republican former prisoners (aged 50 and over) as ...
... (March 14, 2011) Research has shown that playing a ... children, but playing a used instrument also can pose a ... instruments were found to be heavily contaminated with a variety ... minor to serious infectious and allergic diseases, according to a ...
... , MONDAY, March 14 (HealthDay News) -- Watching this year,s ... for those who bet on the games, one expert suggests. ... sites and spoiler message boards seems to suggest that predicting ... according to Stephen M. Nowlis, a marketing professor at the ...
... numerous paths to resist the targeted drug Herceptin, but ... a tumor,s vulnerability to treatment, scientists at The University ... at Nature Medicine . Adding the drug ... cutting off at least five different molecular pathways, each ...
... March 11 (HealthDay News) -- People would prefer to allow ... they know others are watching, says a new study. ... think badly of them if they do something wrong rather ... research in the journal Psychological Science . "Omissions ...
... (HealthDay News) -- A doctor,s empathy can improve the care ... of being a good doctor, according to a new study. ... 2006 and June 2009 by 29 doctors at Thomas Jefferson ... of empathy for patients, while the quality of patient care ...
Cached Medicine News:Health News:Report into well-being and inclusion of former politically motivated prisoners 2Health News:Report into well-being and inclusion of former politically motivated prisoners 3Health News:Is your child's hobby making him sick? 2Health News:Combination overcomes breast cancer resistance to herceptin 2Health News:Combination overcomes breast cancer resistance to herceptin 3Health News:When Someone Is Watching, You're Less Inclined to Do Bad Things 2
Whether you require high flow rates for critical situations or lower rates for others, this insufflator handles both situations equally well, regulated by the preselected pressure....
The TurboFlow 8000 has two separate gas output ports which, unlike many high flow insufflators, use standard-size tubing, each capable of providing up to 20 LPM flow....
Tongs...
ACMI™ COAG Bipolar Laparoscopy Probes provide 360 of hemostatis, bipolar safety, blunt dissection, irrigation, and suction in one instrument....
Medicine Products: